Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Conditions
Multiple Myeloma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Arizona Oncology Associates, Tucson, Arizona, United States
Colorado Blood Cancer Institute, Denver, Colorado, United States
Rocky Mountain Cancer Center, Denver, Colorado, United States
Medical Oncology Hematology Consultants, Newark, Delaware, United States
Florida Cancer Specialists, Lake Mary, Florida, United States
Maryland Oncology Hematology, Columbia, Maryland, United States
Minnesota Oncology Hematology, Minneapolis, Minnesota, United States
Virginia Oncology Associates, Elizabeth City, North Carolina, United States
Oncology Hematology Care, Cincinnati, Ohio, United States
Oncology Associates of Oregon, Eugene, Oregon, United States
TriStar Bone Marrow Transplant, Nashville, Tennessee, United States
Vanderbilt- Ingram Cancer Center, Nashville, Tennessee, United States
Texas Oncology, Austin, Texas, United States
Texas Oncology - San Antonio, San Antonio, Texas, United States
Texas Oncology - Northeast Texas, Tyler, Texas, United States
Virginia Cancer Specialists, Fairfax, Virginia, United States
Blue Ridge Cancer Center, Roanoke, Virginia, United States
Study leads
Peter A. Forsberg, MD
Study Chair
SCRI Development Innovations, LLC